Volume 11, supplement issue 2, December 2013
Proceedings of 20th Pediatric Rheumatology European Society (PReS) Congress
423 articles in this issue
-
-
-
-
PReS-FINAL-1004: Can the cd4/cd8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
Authors (first, second and last of 8)
-
PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
Authors (first, second and last of 7)
-
-
-
-
PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus
Authors (first, second and last of 7)
-
-
-
-
PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases
Authors (first, second and last of 6)
-
Pres-FINAL-2009: Pediatric rheumatology practitioners experience with biologics in juvenile dermatomyositis: survey results
Authors (first, second and last of 4)
-
PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
Authors (first, second and last of 11)
-
PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis
Authors (first, second and last of 11)
-
PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
Authors (first, second and last of 11)
-
PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
Authors (first, second and last of 5)
-
-
PReS-FINAL-2015: Demographic, clinical and laboratory features of juvenile dermatomyositis in Croatia: retrospective study over the last 22 years
Authors (first, second and last of 7)
-
PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
Authors (first, second and last of 4)
-
PReS-FINAL-2017: Systemic onset juvenile idiopathic arthritis (SOJIA)-a 5-year survey in a pediatric rheumatology department
Authors (first, second and last of 4)
-
PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis
Authors (first, second and last of 7)
-
-
-
PReS-FINAL-2021: JADAS-CRP instead of JADAS-ESR...results from REUMA.PT
Authors (first, second and last of 19)
-
-
PReS-FINAL-2023: Uveitis surveillance through lean-six sigma for quality assurance in juvenile idiopathic arthritis
Authors (first, second and last of 5)
-
PReS-FINAL-2024: Responsiveness of the juvenile arthritis foot disability index
Authors (first, second and last of 5)
-
PReS-FINAL-2025: Arthritis associated with human immunodeficiency virus
Authors (first, second and last of 5)
-
-
-
-
-
-
PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis
Authors (first, second and last of 6)
-
-
-
-
PReS-FINAL-2035: Fatty acid profiling: potential new biomarkers in JIA
Authors (first, second and last of 4)
-
PReS-FINAL-2036: Proteins of the lectin pathway of the complement system in juvenile idiopathic arthritis
Authors (first, second and last of 5)
-
PReS-FINAL-2037: Association between clinical and microbiological periodontal condition in Colombian patients with juvenile idiophatic arthritis
Authors (first, second and last of 7)
-
PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA
Authors (first, second and last of 4)
-
-
-
PReS-FINAL-2041: Macrophage activation syndrome in the children with systemic juvenile idiopathic arthritis during the course of tocilizumab
Authors (first, second and last of 9)
-
-
PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
Authors (first, second and last of 6)
-
PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
Authors (first, second and last of 4)
-